FDA Opts For MedGuide, Not Black Box For Anti-Epileptic Suicidality

FDA has made a decision on how to communicate the suicidality risk for anti-epileptic drugs: with the first novel approvals in that class since an advisory committee on the topic, FDA has opted for a Medication Guide over a "black box" warning